MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VIVEROS, O. H.
Right arrow Articles by KIRSHNER, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VIVEROS, O. H.
Right arrow Articles by KIRSHNER, N.

Molecular Pharmacology, Vol 5, 342-349, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Mechanism of Secretion from the Adrenal Medulla

V. Retention of Storage Vesicle Membranes following Release of Adrenaline

O. H. VIVEROS 1, L. ARQUEROS 1, and N. KIRSHNER 1

1 Department of Biochemistry, Duke University Medical Centre, Durham, North Carolina 27706

Dopamine beta-hydroxylase (EC 1.14.2.1) was used as a marker to follow the fate of the adrenal storage vesicles following the release of adrenaline. Neurogenic secretion of adrenaline induced by insulin produced a decrease in the adrenaline and dopamine beta-hydroxylase contents of the gland. There was only a slight decrease in the enzyme activity of the particulate fraction obtained from lysed storage vesicles, but a marked decrease in the activity of the soluble fraction. Twenty-four hours after the administration of reserpine (1 mg/kg) to rabbits, changes in the dopamine beta-hydroxylase activity were similar to those observed after insulin treatment, but the glands were more severely depleted of their catecholamines. After lower doses of reserpine (0.25 mg/kg), or if ganglionie transmission was blocked by chlorisondamine 1 hr prior to the administration of reserpine (1 mg/kg), there were significant decreases in the catecholamine content but no changes in the dopamine beta-hydroxylase activity. These findings indicate that neurogenic secretion is characterized by release of the soluble content of the storage vesicles directly to the exterior of the cell and retention of the storage vesicle membranes within the cell. Interference only with time uptake or storage mechanism by reserpine results in depletion of the catecholamine content, but not of the intravesicular protein.

Submitted on February 1, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics